FDA Approved: EMTRIVA — Supplemental Application (Gilead Sciences, Inc.)

View source ↗

Summary

FDA approved a supplemental application for EMTRIVA (emtricitabine) submitted by Gilead Sciences.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Viral Hepatitis

Drugs mentioned

• Emtriva (emtricitabine)

Snippet

SUPPL AP for EMTRIVA (EMTRICITABINE)